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Abstract
Inflammation has long been implicated as a contributor to pathogenesis in many CNS illnesses, including Lyme
neuroborreliosis. Borrelia burgdorferi is the spirochete that causes Lyme disease and it is known to potently induce the
production of inflammatory mediators in a variety of cells. In experiments where B. burgdorferi was co-cultured in vitro with
primary microglia, we observed robust expression and release of IL-6 and IL-8, CCL2 (MCP-1), CCL3 (MIP-1a), CCL4 (MIP-1b)
and CCL5 (RANTES), but we detected no induction of microglial apoptosis. In contrast, SH-SY5Y (SY) neuroblastoma cells co-
cultured with B. burgdorferi expressed negligible amounts of inflammatory mediators and also remained resistant to
apoptosis. When SY cells were co-cultured with microglia and B. burgdorferi, significant neuronal apoptosis consistently
occurred. Confocal microscopy imaging of these cell cultures stained for apoptosis and with cell type-specific markers
confirmed that it was predominantly the SY cells that were dying. Microarray analysis demonstrated an intense microglia-
mediated inflammatory response to B. burgdorferi including up-regulation in gene transcripts for TLR-2 and NFkb.
Surprisingly, a pathway that exhibited profound changes in regard to inflammatory signaling was triggering receptor
expressed on myeloid cells-1 (TREM1). Significant transcript alterations in essential p53 pathway genes also occurred in SY
cells cultured in the presence of microglia and B. burgdorferi, which indicated a shift from cell survival to preparation for
apoptosis when compared to SY cells cultured in the presence of B. burgdorferi alone. Taken together, these findings
indicate that B. burgdorferi is not directly toxic to SY cells; rather, these cells become distressed and die in the inflammatory
surroundings generated by microglia through a bystander effect. If, as we hypothesized, neuronal apoptosis is the key
pathogenic event in Lyme neuroborreliosis, then targeting microglial responses may be a significant therapeutic approach
for the treatment of this form of Lyme disease.
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Introduction
Lyme borreliosis is the most prevalent vector-borne illness in the
northern hemisphere [1,2]. Transmission from the animal
reservoir to the human host occurs via an Ixodes tick bite into
the skin, where B. burgdorferi, the spirochete that causes Lyme
disease, can then disseminate hematogenously to various organs,
including the heart, joints and both the peripheral and central
nervous systems [2–4]. A prominent, recurring and yet only
partially understood feature of Lyme disease is the presence of
inflammatory infiltrates within infected tissues [1–5]. Evidence of
neurological involvement occurs to varying degrees in both the
central and peripheral nervous systems of Lyme disease patients,
and inflammation is often associated with the neurological
manifestations that define neuroborreliosis [2,5–8,9,10]. Upon
gaining access to the central nervous system (CNS), B. burgdorferi
may induce cerebrospinal fluid pleocytosis, meningoradiculitis and
cranial neuritis as well as encephalopathies with neurocognitive
abnormalities [3,5,6,11]. This complex process of B. burgdorferi-
induced pathology in the CNS has many aspects as yet to be
clarified, with reactive inflammation potentially being one of the
principal contributors to neuronal dysfunction.
Although B. burgdorferi lacks lipopolysaccharide (LPS), the
organism does produce spirochetal lipoproteins that can induce
inflammation [11–17]. By signaling through CD14, binding Toll-
like receptors (TLR) 2 and 1 and subsequent activation of NFkb,
lipoproteins have been shown to generate inflammatory mediators
in a variety of cell types [14,18–21]. Recent studies with TLR2
and/or MyD88-deficient mice in which B. burgdorferi-induced
inflammatory infiltrates were greater than that of wild type
controls, indicated however, that there are alternative pathways
regulating the inflammatory response to infection with B. burgdorferi
[11,22,23]. As neuronal dysfunction is further analyzed in the light
of these findings, it becomes necessary to consider which cells of
the CNS milieu can function most aggressively/efficiently in
creating an inflammatory environment that will contribute to
clearance of the pathogen, but may in the process, harm nearby
neurons.
Using in vitro and ex vivo experiments, investigators have shown
that B. burgdorferi can induce potent production of inflammatory
cytokines and chemokines in microglia, the resident macrophage
cells of the CNS [2,6,12,24]. The secretion of these mediators is
likely a vital step in the development of inflammatory reactions,
as chemokines, depending on their CC/CXC family sequence,
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lymphocytes or neutrophils to sites of inflammation. Addition-
ally, many cytokines and chemokines become involved in
apoptosis, cell cycle regulation and angiogenesis [3,6,23,25–
28]. While a similar response is observed in astrocytes, the
repertoire range and scale of concentration is typically much
lower than that of activated microglia [2,12,29]. Importantly,
although astrocytes are considered to be the primary CNS
support cells, activated microglia can also secrete a host of
soluble agents, such as glia-derived neurotrophic factor, that are
potentially neuroprotective [30–32]. As the majority of mole-
cules produced by activated microglia are however considered to
be pro-inflammatory and neurotoxic [2,30,31,33], the microglial
response to CNS infection with B. burgdorferi could tip the scales
toward neuronal damage and death rather than survival in Lyme
neuroborreliosis.
We have argued that the associated neurocognitive symptoms of
Lyme neuroborreliosis may be the result of neuronal dysfunction
resulting from inflammatory mediators released in response to
infection with B. burgdorferi. Serving as an in vivo proof of concept to
this hypothesis, our laboratory has recently shown the production
of IL-6 by astrocytes, as well as the induction of oligodendrocyte
and neuronal apoptosis in brain tissues taken from rhesus
macaques that received intraparenchymal stereotaxic inoculations
of live B. burgdorferi [6]. With the goal of beginning to establish
cause and effect relationships between glial cell responses to B.
burgdorferi and neuronal apoptosis, we quantified the production/
secretion of inflammatory cytokines and chemokines in purified
rhesus brain cortex microglia and astrocytes, in human neuronal
cells from the SH-SY5Y (SY) neuroblastoma cell line, and in
combinations of the above cells co-cultured with live B. burgdorferi
or recombinant purified lipidated outer-surface protein A
(L-OspA). SY cells were cultured in three dimensions as opposed
to monolayer culture, as we had shown that that mode of
cultivation significantly narrows the phenotypic gap between
neuronal cell lines and primary neurons [34]. We also determined
the extent of B. burgdorferi-induced apoptosis in each of the above
cellular combinations. Using microarray analysis, we further
examined the principal inflammation and apoptosis pathways
affected by B. burgdorferi in these cells. Our findings suggest a
bystander effect in which the neurotoxic surroundings generated
by microglia may contribute to neuronal cell damage.
Materials and Methods
Ethics statement
Brain tissues used in this study were collected from rhesus
macaques (Macaca mulatta). These animals were not experimentally
infected with B. burgdorferi and were culled from the breeding
colony because of chronic diarrhea or injury. The procedure used
for euthanasia was consistent with the recommendations of the
American Veterinary Medical Association’s Panel on Euthanasia
and was approved by Tulane University’s Institutional Animal
Care and Use Committee.
Media and reagents
Dulbecco’s modified Eagle’s medium (D-MEM)-F-12 with
L-glutamine and 15 mM HEPES buffer, D-MEM high glucose
with L-glutamine, F-12 (Ham) with glutamax, penicillin
(100 units/ml), streptomycin (100 units/ml), amphotericin B
(0.25 mg/ml), non essential amino acids (NEAA) (100 units/ml),
sodium pyruvate (100 units/ml), sodium bicarbonate (7.5%
solution), trypsin (0.25%)/EDTA (0.38 g/ml), trypan blue
TM,
normal goat serum (NGS), Alexa-562 (red)-conjugated secondary
antibody, and the ToPro (blue) nuclear stain were each from
Invitrogen. Primocin was from Invivogen. Fetal bovine serum was
from Hyclone/Thermo Scientific and Cytodex-3
TM micro-carrier
beads were from Amersham Biosciences. Granulocyte-macro-
phage colony-stimulating factor (GM-CSF), L-leucine methyl ester
(LME), Barbour-Stoenner-Kelly-H medium with rabbit serum,
rifampicin, amphotericin, fish skin gelatin (FSG), propidium iodide
(PI) (red) and anti-GFAP antibody were from Sigma-Aldrich.
Lipidated (L-OspA) and unlipidated (U-OspA) outer surface
protein A were a kind gift from GlaxoSmithKline. Paraformalde-
hyde (PFA, 2%) was from USB Corporation, and Triton X-100
from ICN Biochemicals. HuD primary antibody was from Santa
Cruz Biotechnology. IBA-1 antibody was from WAKO.
Cell isolation and culture
Primary glia. Brain tissues used in this study were collected
from rhesus macaques (Macaca mulatta). These animals were not
experimentally infected with B. burgdorferi and were culled from the
breeding colony because of chronic diarrhea or injury. Tissue was
removed from the cortical region of the brain and processed as
follows. After removal of the leptomeninges and leptomeningeal
blood vessels, the cortex tissue was first dissociated mechanically
by mincing the tissue with a sterile scalpel. Enzymatic dissociation
followed by resuspending the minced tissue in D-MEM-F-12
medium with 0.25% trypsin-EDTA, 0.1% DNase and primocin
(100 mg/ml), at 37uC for approximately 30 minutes, with
occasional manual shaking. The solution was then centrifuged
(425 x g, 10 minutes), the upper layer of cells removed, passed
through a 20 mm Nitex filter and resuspended in D-MEM-F-12
with 10% FBS, 0.5 ng/ml GM-CSF and primocin antibiotic/
antimycotic. After an incubation of approximately 10 days to 4
weeks at 37u in a 5% CO2, humid atmosphere incubator,
microglia could be dislodged and recovered by vigorously tapping
the culture flasks. The astrocyte cells were purified of any
remaining microglia by removal of the GM-CSF component
from the medium and subsequent treatment with 25 mM
L-leucine methyl ester (LME) for 60 minutes at room
temperature. Purity of both the astrocyte and microglial cell
cultures was assessed to be approximately 98 percent and was
confirmed by staining with GFAP and IBA-1. The culture was
Author Summary
Lyme disease, which is transmitted to humans through the
bite of a tick, is currently the most frequently reported
vector-borne illness in the northern hemisphere. Borrelia
burgdorferi is the bacterium that causes Lyme disease and
it is known to readily induce inflammation within a variety
of infected tissues. Many of the neurological signs and
symptoms that may affect patients with Lyme disease have
been associated with B. burgdorferi-induced inflammation
in the central nervous system (CNS). In this report we
investigated which of the primary cell types residing in the
CNS might be functioning to create the inflammatory
environment that, in addition to helping clear the
pathogen, could simultaneously be harming nearby
neurons. We report findings that implicate microglia, a
macrophage cell type in the CNS, as the key responders to
infection with B. burgdorferi. We also present evidence
indicating that this organism is not directly toxic to
neurons; rather, a bystander effect is generated whereby
the inflammatory surroundings created by microglia in
response to B. burgdorferi may themselves be toxic to
neuronal cells.
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purified for either specific cell type.
Neuroblastoma cells. Human SY neuroblastoma cells
[American Type Culture Collection (ATCC) CRL-2266] were
seeded into T75 flasks with medium renewal every 3–7 days. Cell
propagation was performed as per the ATCC product sheet.
Three-dimensional (3-D) cultures were then prepared as
previously described [34]. For any SY cell co-culture with glia
or B. burgdorferi, SY cell culture complete growth medium was used.
This medium was composed of a 1:1 mixture of D-MEM high
glucose with L-glutamine and F-12 medium. Penicillin,
streptomycin and amphotericin B were added to the medium
only when spirochetes were not present. Trypsin/EDTA was used
to dislodge the cells in both neuronal and glia cultures, and trypan
blue stain was used to assess cell viability.
Bacterial culture. B. burgdorferi was cultured as previously
described [12] with limited modifications. When combined in any
co-culture with glia and/or SY cells, the described appropriate
mammalian cell culture medium was used, but without the
addition of antibiotics and antimycotic. While B. burgdorferi did not
divide in any of the mammalian culture media used, spirochetal
viability was determined to be above 85% in all assays. The
LIVE/DEAD BacLight bacterial viability kit (Invitrogen) was used
as per the manufacturer’s instructions, to determine viability at
both 24 hours and 5 days during co-culture with glia and/or SY
cells. B. burgdorferi was additionally cultured in the mammalian cell
medium alone to confirm proliferation rates and viability.
Transwell culture
Three-micrometer pore diameter polyester transwell culture
inserts (Becton Dickinson, Falcon) were incorporated into our
co-culture models to physically separate SY cells from
microglia. The SY cells were seeded directly into 24 well
dishes (Costar) with the microglia then seeded onto culture
inserts that had been placed into the same wells as the SY cells.
The cell density in these experiments was 1610
5 cells per ml of
culture medium with an initial microglia to neuronal cell ratio
of 4:1. Live B. burgdorferi was added to the culture medium in
both chambers for a 5-day stimulation, at an MOI of 10:1, in
relation to the entire cell population. In this way, it was
possible to maintain a generally homogeneous exposure of
each cell type to the culture medium while still allowing for
bidirectional transfer of secreted molecules between the cell
types.
Quantification of cytokines
Supernatants collected from primary glia and/or SY cells co-
cultured with B. burgdorferi (MOI 10:1) or in medium alone for
either 24 hours or 5 days were used for quantification of secreted
cytokines and chemokines. All of the mammalian cells were seeded
at a density of 5610
4 cells per 500 ml of culture medium with a
glial cell to SY cell ratio of 4:1. The 27-cytokine bioplex assays
(Bio-Rad) were performed according to manufacturer’s directions
as were the individual antigen-capture ELISAs for IL-6, IL-8,
TNF, CCL3, CCL4, and MCP-1 (CCL2). Sandwich ELISA
capture and detection antibody pairs for human IL-6, IL-8 and
TNF, along with recombinant human IL-6, IL-8, TNF and
horseradish peroxidase (HRP) were from BD Biosciences. We
obtained CCL3 and CCL4 ELISA DuoSet kits and the MCP-1
(CCL2) kit from R&D Systems.
Determination of nitric oxide production
Supernatants collected from primary glia and/or SY cells
co-cultured with B. burgdorferi (MOI 10:1) or in medium alone for
either 24 hours or 5 days were used for quantitative determination
of total secreted nitric oxide. The mammalian cells were seeded at
a density of 5610
4 cells per 500 ml of culture medium with an
initial glial cell to SY cell ratio of 4:1. The Total Nitric Oxide
Assay Kit (catalogue #917–020) from Assay Designs was used,
and all analyses were performed according to directions from the
manufacturer.
Apoptosis assays, confocal microscopy
Microglia, astrocytes, SY cells or combinations thereof were
cultured in the presence of B. burgdorferi (MOI 10:1) or medium
alone for either 24 hours or 5 days. After removal of the
supernatant, the cells were harvested using trypsin, washed in
phosphate buffered saline (PBS), and fixed for 5–10 minutes in
2% PFA. The fixed cells were permeabilized in PBS/FSG/
Triton and blocked with 10% NGS. Apoptosis was evaluated
using the Apoptag TUNEL assay kit (Chemicon/Millipore) as
per manufacturer’s instructions and the results were analyzed
using a Leica TCS SP2 confocal microscope equipped with 3
lasers. Briefly, 6–18 0.2-mm optical slices per image were
collected at 5126512 pixel resolution. In order to distinguish
SY cells in the co-cultures containing glia, the cells were
additionally stained with primary anti-HuD antibody for
1 hour, washed 3 times in PBS and then stained with Alexa
562-labeled secondary antibody for 45 minutes. The To-Pro
nuclear stain was combined with the secondary antibody at a
concentration equal to 0.05 mg/ml. The identities of microglia
and astrocytes were additionally confirmed using the above
protocol, substituting anti-IBA-1 and anti-GFAP respectively,
for the anti-HuD. Cell morphology consistent with apoptosis
including cell shrinkage, nuclear condensation and membrane
blebbing was assessed along with the fluorescein staining for
TUNEL. The number of apoptotic cells counted was divided
by the total (500 minimum) number of cells counted. When the
assays included co-culture of SY cells with glia, the number of
cells that were double- stained for apoptosis and neuron
specificity were divided by the total number of cells displaying
the neuronal marker stain. Statistical significance was evalu-
ated by One Way analysis of variance (ANOVA) followed by
Bonferroni, Tukey and Levine’s tests.
Microarray analysis
RNA was isolated from approximately 5610
6 isolated SY cells
or microglia using the RNeasy kit (Qiagen) plus DNA-free
(Ambion) to eliminate DNA contamination. Five hundred
nanogram of total RNA was amplified and used to synthesize
Cy-labeled cDNA with the Low RNA Input Linear Amplification
Kit (LRILAK, Agilent Technologies). Cy3 (control) and Cy5
(experimental) labeled cDNA were mixed in equimolar quantities
and hybridized overnight at 55uC, to Agilent whole-genome
microarrays (4644 k format). While the samples derived from
macaque microglia were hybridized to rhesus macaque arrays
(Agilent # G2519F) with over 44,000 rhesus macaque probes,
representing approximately 18,000 individual annotated genes,
the samples derived from the neuronal cells were hybridized to
human genome arrays (Agilent # G4112F) with over 41,000
oligonucleotides, representing approximately 22,000 unique
human genes. The slides were scanned on a GenePix 4000B
scanner, and data were extracted from the resulting 16-bit TIFF
images using GenePix Pro 6.1 software. Data were analyzed using
Spotfire DecisionSite for Microarray Analysis. Values were log2
transformed and normalized using a Locally Weighted ScatterPlot
Smoothing (LOWESS) script within S+ ArrayAnalyzer.
Bb-Induced Neuronal Apoptosis
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RNA was isolated from approximately 5610
6 isolated microglia
or neuronal cells using the RNeasy kit (Qiagen) plus DNA-free
(Ambion) to eliminate DNA contamination. The RNA was
reverse-transcribed into DNA using a OneStep RT-PCR kit
(Qiagen) and the QuantiFast
TM SYBRH Green PCR kit (Qiagen)
was then used for the quantitative real-time (QRT)-PCR. All
assays were performed according to directions from the manufac-
turer and using Qiagen QuantitectH primer pairs in a 96-well
block Applied Biosystems 7900 HT fast RT PCR System. PCR
efficiencies, average fold change and statistical significance were
evaluated using REST software.
Results
B. burgdorferi upregulates the expression of
inflammatory cytokines/chemokines in primary rhesus
glia but not in SY neurons
In experiments where B. burgdorferi or recombinant L-OspA was
co-cultured with isolated rhesus cortex glia, we observed robust
expression and release of IL-6 and IL-8 (Figure 1A). We also
observed the production of TNF, although at a much lower level,
and only by microglial cells and cells in the aggregate cultures,
which themselves contained microglia (Figure 1A insert). SY cell
production of IL-6 and IL-8 in response to B. burgdorferi and
L-OspA were below the limit of detection for the assay used.
Cytokine/chemokine expression levels in response to the same
stimuli often varied significantly in glial cells obtained from
different animals. The patterns of expression, however, were
reproducible in experiments where the glial cells were isolated
from tissue originating from a single individual animal. As such,
the highest response was always that of microglia, followed by that
of aggregate cultures and then astrocytes, regardless of the animal
from whom the cells had been obtained. With the exception of
TNF, whose expression peaked at 24 hours and then declined,
levels of cytokine/chemokine expression also increased with the
time of stimulation (Figure 1B).
As the inherent difficulties in culturing primary neurons [35,36]
often render their use in experiments impractical, the neuroblas-
toma cell line SH-SY5Y was employed to assess neuronal
responses. We used a three-dimensional (3D) rather than
traditional monolayer (2D) culture for the SY cells, as this culture
method has been shown to promote a more normal, untrans-
formed phenotype as compared to that of transformed cells grown
in 2D [34,35,37–45].
Neuronal apoptosis occurs in the inflammatory
environment created by microglia in response to B.
burgdorferi
In order to assess endpoint damage to the glia and SY cells
responding to co-culture with B. burgdorferi or L-OspA, we
employed the terminal deoxynuclease dUTP nick end labeled
(TUNEL) assay as a tool for visualization of apoptosis. When
microglia isolated either alone or in aggregate with astrocyte cells,
were co-cultured with both B. burgdorferi and SY for at least 5 days,
increases in cellular apoptosis consistently occurred. Apoptosis in
glial cells was minimal as compared to the un-stimulated controls
and there were no remarkable changes in apoptotic levels with
regard to individual animals. SY cells cultured for 5 days with B.
burgdorferi alone, or in combination with astrocytes and B.
burgdorferi, showed only baseline levels of apoptosis (Table 1). No
significant increase in astrocyte apoptosis was observed whether
these cells were incubated with other cell types, L-OspA or B.
burgdorferi (Table 1). Confocal microscopy images of mixed cultures
stained for TUNEL and with cell-specific markers indicated that
the majority of cells dying in response to B. burgdorferi were SY cells
(Figure 2A). In consideration of these findings, we focused our next
experiments on SY cells cultured in the presence of microglial cells
and B. burgdorferi for 5 days. Significant increases in SY cell
apoptosis occurred consistently in cell cultures from each of the 4
animals sampled when both microglia and B. burgdorferi were
included in the culture conditions (Figure 2B).
In order to determine whether stimulation of the culture
medium with IL-6, IL-8, TNF or combinations thereof would be
sufficient to induce apoptosis in the SY cells, we conducted
experiments in which concentrations of each cytokine (recombi-
nant-human) were added to the neuronal medium that were
Figure 1. B. burgdorferi induces the expression of inflammatory
mediators in primary rhesus CNS glial cells but not in SY cells.
(A) Sandwich ELISA shows prominent increases in IL-6 and IL-8
expression/secretion by primary cultures of rhesus cortex glia in the
presence of lipidated outer-surface protein A (L-OspA): 0.25 mg/ml, or B.
burgdorferi (Bb; MOI of 10:1), for 24 hours, and (B) for 5 days.
Unlipidated outer-surface protein A (U-OspA): 0.25 mg/ml, was used as
the control for L-OspA. While a slight U-OspA-induced increase in IL-8
expression was observed in the microglia samples at 24 hours, this
increase was not statistically different from control values. TNF
expression was only observed in cultures containing microglia, where
it peaked at 24 hours and was not observed at 5 days. Neuron
responses were absent or negligible in comparison to that of the glial
cells at both time points. In order to better visualize TNF expression, the
Y axis in Figure 1A was expanded (insert). Values on each graph are
from a single representative animal where depending on the stimulus
and time of incubation, each experiment was repeated in 3 or more
rhesus macaques. Error bars represent standard deviation of replicates
on the plate where n=3.
doi:10.1371/journal.ppat.1000659.g001
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vitro assays with microglia and SY cells. After a 5 day stimulation,
we did not find increases in neuronal apoptosis comparable to
those observed in the co-culture of SY cells with microglia and B.
burgdorferi, or significantly above the baseline levels of SY cells
cultured in medium alone (data not shown).
Potent and sustained expression of the chemokines
CCL2, CCL3, CCL4 and CCL5, in addition to that of IL-6
and IL-8, contributes to maintaining the inflammatory
environment created by microglia in response to B.
burgdorferi
In view of the evidence indicating that microglia were the more
robust responders to the inflammatory stimuli of B. burgdorferi
(Figure 1), and that molecules other than, or in addition to IL-6,
IL-8 and TNF were required to elicit SY cell apoptosis, we further
explored the diversity of mediators produced by microglia in
response to B. burgdorferi. As several investigators had reported that
the activated glia seen in many CNS pathologies were able to kill
neurons by the release of nitric oxide (NO) into their surrounding
environments [46–48], and knowing that B. burgdorferi could elicit
the release of NO from exposed macrophages [49], we explored
this possibility in our models. Using an adaptation of the Greiss
reaction, we were not able to detect any significant release of NO
into the supernatant of microglia, astrocytes, SY cells or any
combinations of the three cell types co-cultured with B. burgdorferi
for either 24 hours or for 5 days (data not shown).
Using a 27 cytokine Bio-Plex assay to expand on our previous
data, we found along with IL-6 and IL-8, significant B. burgdorferi-
induced upregulation in expression of the pro-inflammatory
chemokines CCL2, CCL3, CCL4 and CCL5 by microglial cells
(Table 2). L-OspA (0.25 mg/ml) was observed to elicit a
comparable upregulation of cytokines in both microglia and
astrocytes, indicating that B. burgdorferi lipoproteins may elicit the
lion’s share of the spirochetal stimulus. However, when microglia
were present in the cultures, alone or with astrocytes (aggregate
cultures), it appeared that spirochetes provided, overall, the
stronger stimulus. SY cell responses were absent or minimal in
comparison to that of the microglia, except for the production of
vascular endothelial growth factor (VEGF) (Table 2), which has
been increasingly implicated as a contributing factor in neuronal
protection and survival [50–53].
B. burgdorferi induced significant cytokine/chemokine expression
in astrocytes, but expression levels were generally orders of
magnitude lower than those of microglia that had been derived
from the same tissue (Table 2). These results, combined with our
previous cytokine and apoptosis assays, prompted us to focus on
interactions of microglia with SY cells in the presence of B.
burgdorferi, and to broaden our exploration of pathways involved in
microglial activation and neuronal apoptosis.
Multiple inflammatory signaling pathways are activated
in microglia exposed to B. burgdorferi
We used microarray analysis to further investigate how
exposure to B. burgdorferi might affect global gene expression in
microglial cells. As changes in the expression and activity of
multiple genes often work in concert to affect responses to many
cellular pathogens, including B. burgdorferi [10,54–56], we used
Ingenuity Pathways Analysis software to compare transcript levels
in 18,000 annotated rhesus genes. When microglia were cultured
in the presence of B. burgdorferi, as compared to medium alone, five
of the ten most altered canonical pathways, as well as the
chemokine signaling pathway (number 19 on the list of 232
affected pathways), showed significant upregulation in inflamma-
tory signaling (Figure 3A).
Many of the transcript changes that occurred within the
triggering receptor expressed on myeloid cells-1 (TREM1), pattern
recognition receptors (PRR), IL-10, IL-6 and chemokine signaling
(Chem. Sig.) pathways were proinflammatory and they were
repeated in several pathways that included both innate and
adaptive immune responses (Table 3). Interestingly, the pathway
that exhibited the most profound changes in regard to inflamma-
tory signaling was TREM1 (Figure 3B, Table 4).
TREM1 cell surface receptors associate with the adaptor
molecule DAP12 for signaling and function and have been
classified as immune/inflammatory response amplifiers. Although
the receptor has thus far not been found to be expressed on
microglial cells [55,57–61], our array data indicate that it is
expressed in rhesus microglia, or a subpopulation thereof, and is
also upregulated during infection with B. burgdorferi. A low level of
TREM1 expression in rhesus microglia was confirmed by RT-
PCR (data not shown). RT-PCR was further used to confirm
significant transcript up-regulation in the following three selected
molecules: CCL2 (TREM1 and Chem. Sig. pathways), IL-6
(TREM1, PRR, IL-10 and IL-6 pathways) and CCL5 (PRR and
Chem. Sig. pathways), (Table 5). Individual transcript changes for
both animals sampled can be accessed online through the
supplemental data portion of this report (Tables S1 and S2).
Table 1. Borrelia burgdorferi-induced apoptosis in SH-SY5Y
(SY) neurons and primary rhesus glia.
%Apop in
Single Cell
Culture
%Apop in
Glia+SY
Culture (Glia)
%Apop in
Glia+SY
Culture (SY)
SY 1.6
SY+L-OspA 2.1
SY+U-OspA 1.9
SY+Bb 1.6
A 0.2 1.5 1.6
A+L-OspA 0.4 0.7 1.6
A+U-OspA 0.3 3.4 3.8
A+Bb 0.6 1.5 2.0
mG 0.9 3.7 5.4
mG+L-OspA 0.5 0.5 2.3
mG+U-OspA 1.9 0.8 1.0
mG+Bb 1.1 3.6 14.8
Agg 0.7 0.8 2.4
Agg+L-OspA 0.2 1.4 1.5
Agg+U-OspA 0.2 0.9 1.9
Agg+Bb 0.6 3.4 12.0
The TUNEL assay was used to measure apoptosis in combinations of neurons
and glia that were cultured for 5 days in medium alone, or in the presence of
lipidated outer-surface protein A (L-OspA) (0.25 mg/ml), Un-lipidated outer
surface protein A (U-OspA) (0.25 mg/ml) or Borrelia burgdorferi (Bb) at a
multiplicity of infection (MOI) 10:1. Induction of apoptosis above baseline
occurred only in the neurons and importantly, only in those that were co-
cultured in the presence of both Bb and microglia. Values shown are from a
single representative animal. SY: SHSY5Y ‘‘n’’ type neuroblastoma cells; A:
astrocytes; mG: microglia; Agg: astrocytes and microglia in proportion of original
primary culture.
doi:10.1371/journal.ppat.1000659.t001
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Signaling in SY cells
In addition to affecting the environment surrounding neurons
exposed to B. burgdorferi, activated microglia may also affect gene
expression of neurons themselves. Microarray analysis for the p53
Signaling pathway revealed a microglia-induced shift in the gene
expression of SY cells co-cultured with B. burgdorferi from one of
cell survival and proliferation to one more in line with cell cycle
arrest and apoptosis (Figure 4A and 4B).
In cultures containing only SY cells and B. burgdorferi, there were
prominent increases in transcript for the cell survival and anti-
apoptotic molecules protein kinase B (AKT1) and BCL2-like
(Bcl-XL) genes, combined with a decrease in transcript for pro-
apoptotic damage-regulated autophagy modulator (DRAM)
(Table 6-left, Figure 4A).
This scenario, however, changed dramatically in experiments
when microglia were included in the co-culture of SY cells with B.
burgdorferi (Figure 4B, Table 6, right). In order to study microglia-
induced gene expression changes in the SY cells, transwell inserts
were incorporated into the culture system providing physical
separation between the SY cells and the microglial cells, yet
allowing for bidirectional transfer of secreted molecules between
the cell types. In this model, gene expression for phosphatase and
tensin homolog (PTEN), which functions to modulate cell survival
and proliferation primarily through its downstream effects on
AKT1, was shown to be significantly increased (Table 6, right). SY
Figure 2. Neuronal apoptosis occurs in the inflammatory environment created by microglia in response to B. burgdorferi. (A) Cell
specific markers and a separate nuclear stain were combined with the TUNEL assay. TUNEL: FITC (green), neuron specific marker: HuD (red), nucleus
specific marker: To-Pro (blue). Confocal microscopy was used to determine that the majority of cells dying by apoptosis in response to B. burgdorferi
were neurons. An accurate total cell number per field was established by counting all of the individual nuclei (blue). An on/off toggle of the laser
channel for the nuclear stain (blue), would allow easy detection of overlap between the cell specific (red) and TUNEL (green) markers (lower panel). As
the SY neuronal cells tend to grow in clusters, multiple panels were counted in order to acquire a proper percentage of each cell type. Total cell
counts typically ranged between 500 and 1000. (B) In experiments focused on SY cells co-cultured with combinations of both microglia (mG) and B.
burgdorferi (Bb), significant increases in SY, but not glial apoptosis consistently occurred. Cell culture in these experiments was performed as above,
but the microglia and aggregate (Agg) cultures were obtained from 4 individual animals. Data represent the mean (n=4) 6 S.D. D = change. P
values were obtained using One Way analysis of variance (ANOVA) followed by Bonferroni, Tukey and Levine’s tests.
doi:10.1371/journal.ppat.1000659.g002
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swing from up to down-regulation in the presence of microglia,
while pro-apoptotic BCL2-associated X protein (Bax) and
phorbol-12-myristate-13-acetate-induced protein 1 (NOXA-1)
transcripts were increased. Additionally, the transcript for cyclin-
dependent kinase 2 (CDK2), which typically drives the cell cycle,
was down-regulated, and the G1/S cell cycle checkpoint
inhibitors, cyclin-dependent kinase inhibitor 1A (p21) and
glycogen synthase kinase 3 beta (GSK3b), were both increased
(Figure 4, Table 6 right). The observed changes for individual gene
transcript levels may be accessed online in the supplemental data
portion of this report (Tables S3 and S4). RT-PCR was used to
confirm transcript changes in selected molecules from co-cultures
of the SY neurons with B. burgdorferi both in the presence and
absence of microglia (Table 7).
The induction of neuronal apoptosis during co-culture
with B. burgdorferi and microglia might require cell-cell
contact between the SY cells and microglia
Several investigators have shown that when in the presence of
certain stimuli, not only can macrophages/microglia induce
apoptosis in neighboring cells through a bystander effect, but that
there might be an additional requirement for cell-cell contact
between the macrophages/microglia and the affected nearby cells
[62–64].
To address the question of whether the microglia-secreted
mediators in our system were enough to stimulate SY cell
apoptosis on their own, we again incorporated transwell inserts
into our co-culture models to physically separate the microglia
from the SY cells while at the same time, maintaining a generally
homogeneous exposure of each cell type to the culture medium.
Parallel assays for B. burgdorferi-induced apoptosis were set up
where one model followed the same experimental design that was
described in Figure 2, and the second model included the addition
of transwell inserts into the co-culture system for the duration of
the experiment. In each case, primary microglia or aggregate cell
isolates from three separate non-human primates were combined
in co-culture for 5 days with SY neurons and B. burgdorferi. Using
the original co-culture format, we found an average 7.7-fold
increase in neuronal apoptosis when SY cells were co-cultured
with microglia and B. burgdorferi as compared to the SY cells
cultured in medium alone. In contrast, no significant changes in
apoptosis levels were observed when the SY cells were co-cultured
with B. burgdorferi, with microglia, or with microglia and B.
burgdorferi using the transwell inserts (Figure 5).
Discussion
Neuroinflammation is thought to be a contributing factor in a
number of neurodegenerative disorders including Alzheimer’s
disease, Parkinson’s disease and multiple sclerosis, as well as in
Lyme neuroborreliosis [6,7,31,65]. Inflammatory mediator levels
are often elevated in these disorders suggesting that they are
actively involved in the disease process [2,6,31,66]. Because
neurological symptoms do occur in many patients with Lyme
disease, and cognitive impairment is often a part of this scenario, it
was important to discover which mediators likely caused the effects
of B. burgdorferi-induced damage in neurons. We hypothesized that
the inflammatory environment generated during a possible in vivo
exposure of glial cells to B. burgdorferi could harm neurons through
a bystander effect. To address this hypothesis, we used in vitro
Table 2. Reactive cytokine/chemokine expression in SH-SY5Y (SY) neurons and glia co-cultured for 5 days in the presence of Bb or
L-OspA.
IL-6 IL-8 CCL2 MCP-1 *CCL3 MIP-1a CCL4 MIP-1b CCL5 RANTES VEGF
SY 0 (60) 0 (60) 0.21 (60.02) 0 (60) 0 (60) 0 (60) 1.1 (60.94)
SY+L-OspA 0 (60) 0.11 (60.06) 1.05 (60.18) 0 (60) 0 (60) 0.14 (60.17) 1.6 (60.56)
SY+Bb 0 (60) 0.34 (60.24) 0.95 (60.01) 0 (60) 0 (60) 0.24 (60.05) 3.4 (60.65)
A 10.4 (61.02) 2.06 (61.0) 10.6 (60.2) 1.68 (60.64) 0.01 (60) 0 (60) 2.99 (60.01)
A+L-OspA 19.0 (64.7) 12.45 (61.62) 47.5 (611.0) 3.17 (61.58) 0.03 (60.01) 0.01 (60) 3.4 (60.6)
A+Bb 15.36 (61.72) 5.89 (61.05) 18.6 (66.4) 8.33 (61.79) 0.05 (60.01) 0 (60) 2.72 (60.29)
A/SY 3.62 (60.23) 0.96 (60.14) 6.95 (61.2) 2.37 (60.88) 0.08 (60.06) 0 (60) 2.89 (60.06)
A/SY+Bb 3.36 (60.39) 1.29 (60.24) 34.4 (68.8) 8.07 (61.32) 0.03 (60) 0 (60) 3.22 (60.4)
mG 6.42 (62.0) 5.33 (60.21) 56.9 (615.4) 7.68 (61.5) 4.99 (60.87) 0.02 (60.01) 1.16 (60)
mG+L-OspA 19.6 (60.65) 29.87 (63.32) 257.0 (628.0) 32.5 (68.98) 14.7 (61.23) 0.23 (60.01) 1.65 (60.1)
mG+Bb 22.8 (60.66) 51.3 (60.53) 272.0 (630.0) 48.55 (621.32) 18.58 (60) 1.73 (60.02) 2.04 (60.09)
mG/SY 1.53 (60.19) 5.6 (62.6) 49.7 (611.4) 7.10 (61.55) 4.93 (60.89) 0.03 (60.03) 0.87 (60.03)
mG/SY+Bb 9.8 (60.02) 41.7 (60.82) 158.67 (64.0) 25.15 (64.25) 8.96 (60.19) 0.37 (6 2.5 (60.34)
Agg 7.6 (61.16) 3.63 (60.33) 37.7 (62.04) 6.55 (61.68) 3.08 (60.79) 0.02 (0.01) 1.74 (60.26)
Agg+L-OspA 55.17 (64.01) 31.5 (60.63) 177.0 (632.1) 12.15 (62.79) 0.12 (60.03) 1.84 (61.67)
Agg+Bb 36.55 (61.93) 60.0 (60.25) 201.0 (646.6) 20.35 (61.48) 12.17 (60) 1.23 (60.14) 2.22 (60.09)
Agg/SY 2.06 (60.03) 2.81 (60.46) 65.8 (61.1) 2.87 (60) 0.08 (60.06) 0.02 (60) 1.61 (60.04)
Agg/SY+Bb 15.23 (60) 60.2 (60) 134.9 (616.2) 15.79 (62.36) 0.84 (60) 1.98 (60)
Microglia (mG) and aggregate cells (Agg), which contain astrocytes and microglia, produce higher concentrations of the inflammatory mediators assessed in response to
Borrelia burgdorferi (Bb) as compared to astrocytes (A) or SY neuronal cells. Lipidated-outer surface protein A (L-OspA) was an important stimulant in this reaction. The
growth factor VEGF, was expressed in neurons equally or more abundantly than glia in response to Bb. Aliquots of glial cell supernatant were all obtained from a single
representative animal during an individual experiment. Values listed are in ng/ml except for *CCL3 which is in pg/ml, followed by a standard error of the mean where n=2.
doi:10.1371/journal.ppat.1000659.t002
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astrocytes, and neurons, the fundamental triumvirate of cells in
the CNS, it was the microglia that most aggressively responded to
interaction with B. burgdorferi. In addition to inducing a
pronounced and sustained production of cytokines and chemo-
kines in microglial cells, B. burgdorferi also activated important
inflammatory signaling pathways in these cells. Together, these
responses potentially contributed to creating a reactive environ-
Figure 3. Microarray analysis of gene expression in primary rhesus microglial cells cultured for 5 days in the presence of B.
burgdorferi, versus microglia cultured in medium alone. (A)Fiveofthetencanonicalpathwaysmostaffectedduringco-cultureofmicrogliawithB.
burgdorferi involved inflammatory signaling (in bold) and occurred incells isolated from each oftwo rhesus macaques sampled. The number in parenthesis
indicates the pathway order of significancein the2nd animal. Bar graph representsthe ratio of geneexpressionin microglia co-cultured withB. burgdorferi
as compared to control microglia cultured in medium alone. Line graph represents significance as –log (p-value) where p,0.05. (B) Microarray analysis of
the triggering receptor expressed in myeloid cells (TREM1) pathway indicates, through transcript up-regulation of numerous pro-inflammatory genes
including MCP-1 (CCL2), IL-6 and lL-8, the tendency for a sustained microglia-generated inflammatory response to B. burgdorferi. Values were obtained
using Ingenuity Pathways Analysis (IPA) software, version 6. Minimum fold change was $2.0 with significance of p,0 . 0 5 .A l lg e n e si nt h i sp a t h w a yw e r e
represented on the array chips. Red: increased gene expression. Green: decreased gene expression. The results displayed in sections (A) and (B) represent
findings from animal number 1. Individual transcript changes for animals 1 and 2 can be accessed through the online supplemental data (Tables S1 and S2).
doi:10.1371/journal.ppat.1000659.g003
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that in addition to inducing SY cell apoptosis through a bystander
effect, there might be a requirement for direct cell-cell contact
between microglia and neurons for end-stage damage to occur.
In early experiments, we determined that when SY cells were
co-cultured in the presence of microglia and B. burgdorferi for at
least 5 days (MOI 10:1), significant increases in SY, but not glial
cell apoptosis occurred. Our experiments also ruled out any B.
burgdorferi related upregulation in the production of nitric oxide.
While previous reports had indicated that L-OspA would induce
significant levels of apoptosis in primary rhesus astrocytes [67], the
L-OspA concentration of 1 mg/ml used in those experiments was 4
times greater than the one used in the current experiments. Using
a formula developed by Norgard, et al. [68] we approximated the
total amount of outer surface lipoproteins correlating to the
number of spirochetes used in our MOI. An L-OspA concentra-
tion of 0.25 mg/ml provided a quantitatively more realistic
representation of lipoproteins present in B. burgdorferi at the MOI
used in our studies. We further discovered that although B.
burgdorferi did induce a potent expression and secretion of the
inflammatory cytokines/chemokines IL-6, IL-8 and TNF in
microglia, additional mediators were required to trigger neuronal
cell apoptosis. These results prompted us to broaden our study of
potential inflammatory mediators, and at the same time, to
explore B. burgdorferi-activated pathways in microglia and SY cells
that might be further contributing to the neurotoxicity demon-
strated in the apoptosis assays.
By expanding our search for the expression of cytokines and
chemokines that were potentially relevant to B. burgdorferi-induced
neurotoxicity we found that in addition to IL-6, IL-8 and TNF, the
four well known proinflammatory chemokines CCL2, CCL3,
CCL4 and CCL5 were significantly upregulated in microglial cells
co-cultured with B. burgdorferi. Upregulation of CC chemokines has
been described both in murine models of neurocysticerosis and
multiple sclerosis (experimental autoimmune encephalomyelitis,
EAE) [69,70]. CCL2 in particular has been shown to play a role in
the pathogenesis of EAE [71]. Perhaps most interesting were the
microarray results showing that each of these molecules, with the
exception of CCL3, was represented in more than one of the
microglial signaling pathways that were most affected by B.
burgdorferi. Considering the high number of inflammatory genes
involved in these pathways and their potential for cross-talk and
downstream regulation, we believe that the TREM1 pathway,
together with those involving PRR, IL-10, IL-6 and Chem. Sig.,
contribute to B. burgdorferi-induced inflammation in the CNS.
Even though some of the remaining affected pathways may
have provided checks and balances to our findings, many of the
transcript changes that occurred in the pathways that we focused
on were proinflammatory and included both innate and adaptive
immune response molecules. As such, there seems to be a
consistent pattern of inflammatory signaling in microglial cells that
is directly associated with the presence of B. burgdorferi, and that
might adversely affect nearby neuronal cells.
When glial cells were co-cultured with B. burgdorferi in the
presence of SY cells the concentration of inflammatory mediators
was often reduced as compared to that elicited in the absence of
SY cells (Table 2). Since we saw no evidence of glial cell apoptosis,
this decrease is most likely due to the reduced number of glial cells,
the main producers of pro-inflammatory mediators that were
included in these cultures. There are reports that apoptotic
neurons co-cultured with microglia may down-regulate microglial
synthesis of pro-inflammatory molecules [32]. Such a mechanism
also may have contributed to the observed reduction, at least in
the case of microglia/SY cell co-cultures.
Table 3. Gene transcripts significantly affected by Borrelia burgdorferi (Bb) in microglia.
Symbol Entrez Gene Name Exp Val Fold D TREM PRR IL-6 IL-10 Chem. Sig.
CASP1 caspase1 (IL1b convertase) q1.335 ** **
CCL2 (MCP-1) chemokine (C-C motif) ligand 2 q2.355 ** **
CCL4 (Mip-1b) chemokine (C-C motif) ligand 4 q1.176 **
CCL5 (RANTES) chemokine (C-C motif) ligand 5 q2.766 ** **
CCL7 (MCP-3) chemokine (C-C motif) ligand 7 q2.178 ** **
CXCL12 chemokine (C-C motif) ligand 12 (stromal cell derived factor 1) q1.640 **
CXCR4 chemokine (CxC motif) receptor 4 q2.036 **
IL-6 interleukin 6 q5.053 ** ** ** **
IL-8 interleukin 8 q3.353 ** **
IL-10 interleukin 10 Q1.531 ** ** **
IL-12b interleukin 12 beta q5.299 **
IL-1a interleukin 1, alpha q5.585 ** **
IL-1b interleukin 1, beta q5.640 ** ** ** **
IL-1R2 interleukin 1 receptor, type II q1.598 ** **
NFkb1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 q1.514 ** ** ** **
NFkb2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 q1.295 ** ** ** **
NOD2 nucleotide-binding oligomerization domain containing 2 q2.258 ** **
TLR2 toll-like receptor 2 q1.641 ** **
TNF tumor necrosis factor (member 2) q1.711 ** ** ** **
Values were obtained using Ingenuity Pathways Analysis software, version 6. Minimum fold change was set at $2 and is shown as ratio, log 2, with p,0.05. All of the
listed pathway genes were represented on the array chips. Pathway abbreviations: TREM: Triggering Receptor Expressed on Myeloid Cells; PRR: Role of Pattern
Recognition Receptors; Chem. Sig.: Chemokine Signaling.
doi:10.1371/journal.ppat.1000659.t003
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activated microglia could invoke changes in their cellular
environment that affected gene expression in proximal SY cells.
When SY cells were co-cultured with B. burgdorferi alone, SY gene
expression for molecules in the p53 signaling pathway indicated a
mode of cell survival and proliferation. This conclusion was
founded on the observed upregulation in transcripts for AKT1 and
Bcl-XL, paired with decreased gene expression for DRAM. AKT1,
which is activated through the phosphatidylinositol 3-kinase
(PI3K) pathway, is known to stimulate cell cycle progression (via
p21 phosphorylation and release from CDK2) and to play an
important role in promoting cell survival through the suppression
of apoptosis [72-74]. Bcl-XL is likewise a strong promoter of cell
survival, but as one of the major anti-apoptotic members of the
conserved Bcl-2 family of proteins, it functions to inhibit
programmed cell death through the control of mitochondrial
membrane permeabilization [75–78]. DRAM on the other hand,
is a lysosomal protein critical for the ability of p53 to induce either
autophagy or programmed cell death [79–81].
In parallel experiments where microglia were included in the
co-culture of SY cells with B. burgdorferi, but physically separated
from the SY cells by transwell inserts, we found a striking change
of circumstance. One primary difference observed with the
inclusion of microglial cells was increased SY cell gene expression
of the tumor suppressor PTEN. This molecule acts as a dual
protein and lipid phosphatase that can modulate cell survival,
proliferation and apoptosis through its downstream effects on
phosphatidylinositol 3-kinase (PI3K) and the AKT1 gene
[72,82,83]. Complementing the PTEN regulation of AKT1 was
a decrease in transcript for CDK2 combined with transcript
increases for the CDK inhibitors p21 and GSK3b. Within the cell
cycle machinery, cyclin-dependent kinases (CDKs) associate with
their respective cyclins to drive a cell through the G1/S
checkpoint. CDK2 associates with cyclin E and during events of
cell stress or DNA damage, p21 can bind the CDK2/cyclinE
complex and induce cell cycle arrest at G1/S. Furthermore,
association of the CDK4 with cyclin D1 can also be disrupted by
the action of GSK3b, which phosphorylates cyclin D1, triggering
its nuclear export and degradation [84–86]. Both of these events, if
realized, would indicate a drift toward cell cycle arrest, which was
not apparent in the transcript changes for the culture of SY cells
with B. burgdorferi, but lacking microglia.
Other significant changes in gene expression were found in
members of the apoptotic Bcl-2 family. Transcript of the anti-
apoptotic Bcl-XL molecule, whose function was described
Table 5. Confirmation of rhesus array results using QRT-PCR.
Gene mG/Bb (fold change) P-value
CCL2 +4.17 0.001
IL-6 +6.62 0.001
CCL5 +11.07 0.001
Transcript RNA collected from microglia cultured in the presence of B.
burgdorferi (Bb) was compared to that of RNA collected from microglia (mG)
cultured in medium alone. RT-PCR reactions were run in triplicate with GAPDH
gene expression used as the reference. PCR efficiencies, average fold change
and statistics were evaluated using REST software.
doi:10.1371/journal.ppat.1000659.t005
Table 4. Molecules associated with TREM1 signaling in microglia co-cultured in the presence of B. burgdorferi for 5 days.
Gene Symbol Entrez Gene Name GenBank/RefSeq Exp Val/Fold Change
CASP1 Caspase 1 NM_ _001223 q1.335
CCL2 chemokine ligand 2 NM_ _002982 q2.335
CCL7 chemokine ligand 7 NM_ _006273 q2.178
CD40 CD40 molecule NM_ _001250 q1.453
CD86 CD86 molecule NM_ _006889 q1.000
CSF2 colony stimulating factor NM_ _000758 q3.064
FCGR28 Fc fragment of IgG NM_ _004001 q2.200
ICAM1 intercellular adhesion molecule 1 NM_ _000201 q1.964
IL-6 interleukin 6 NM_ _000600 q5.053
IL-8 interleukin 8 NM_ _000584 q3.353
IL-10 interleukin 10 NM_ _000572 Q1.531
IL-18 interleukin 1 beta NM_ _000576 q5.640
ITGB1 integrin beta 1 NM_ _033667 q2.078
JAk2 Janus kinase 2 NM_ _004972 q1.907
NFkb1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 NM_ _003998 q1.514
NFkb2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 NM_ _002502 q1.295
NOD2 nucleotide-binding oligomerization domain containing 2 NM_ _022162 q2.258
PLCG2 phospholipase C NM_ _002661 Q1.500
TLR2 toll-like receptor 2 NM_ _003264 q1.641
TLR8 toll-like receptor 8 NM_ _138636 Q1.756
TNF tumor necrosis factor NM_ _000594 q1.711
TREM1 triggering receptor expressed on myeloid cells NM_ _018643 q1.462
doi:10.1371/journal.ppat.1000659.t004
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PLoS Pathogens | www.plospathogens.org 10 November 2009 | Volume 5 | Issue 11 | e1000659Figure 4. The p53 Signaling Pathway indicates a microglial cell-induced shift in the gene expression of SH-SY5Y (SY) cells co-
cultured with B. burgdorferi from one of cell survival to one of preparation for apoptosis. (A) Gene expression for p53 signaling in SY cells
co-cultured with B. burgdorferi exhibits through up-regulation of transcript for protein kinase B (AKT), thrombospondin (TSP)-1 and Bcl2-like (Bcl-XL)
combined with decreased transcript for damage-regulated autophagy modulator (DRAM) and p16, a mode of cell survival and proliferation. (B) The
inclusion of microglial cells in the co-culture of SY cells with B. burgdorferi causes a shift in SY gene expression more in line with preparation for
apoptosis than cell survival. There is increased transcript expression for pro-apoptotic phosphatase and tensin homolog (PTEN), Bcl-2-associatedX
protein (BAX) and phorbol-12-myristate-13-acetate-induced protein (NOXA)-1 genes combined with a reversal to decreased transcript for the anti-
apoptotic molecule Bcl-xL. There is also increased expression of the cyclin-dependent kinase inhibitor, p21 and down-regulation in cyclin dependent
kinase CDK2, both indicating a potential preparation for cell cycle arrest at G1/S. See also, Table 5. Values were obtained using Ingenuity Pathways
Analysis (IPA) software version 6. Fold change was $1.5 with p#0.05. The human array chips contained approximately 22,000 unique annotated
genes and all genes in these pathways were represented on the chips. Red: increased gene expression. Green: decreased gene expression. Microglia
were physically separated from the SY cells by 3.0-micrometer pore diameter transwell culture inserts. Individual transcript can be accessed through
the online supplemental data (Tables S3 and S4).
doi:10.1371/journal.ppat.1000659.g004
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not present to being markedly down-regulated in the neuron/
microglia/B. burgdorferi co-cultures. At the same time, expression of
the pro-apoptotic Bax and NOXA-1 transcripts was found to be
increased. Under normal conditions, Bax is constitutively
associated with ly-XL. During cellular stress, Bax can be activated
by a BH3-only protein such as Bid, Bim or NOXA-1. It may also
be displaced by Bad or Bik molecules which possess Bad-like BH3
domains, but act directly on Bcl-2 or Bcl-XL rather than Bax itself,
freeing it from Bcl-XL to translocate from the cytosol and directly
bind to the mitochondrial membrane, initiating an apoptotic
cascade [75,76,87–89]. AKT1 kinase is responsible for the
phosphorylation of Bad, keeping it tied to its support molecule
14-3-3. In an inactivated state, such as that induced by the up-
regulation of PTEN, Bad may become unphosphorylated,
disassociate from 14-3-3 and move to displace Bax [75,88]. While
the results of in vitro experiments may not always mirror in vivo
responses, this compilation of neuronal transcript changes in the
p53 signaling pathway appears to be predicated on the presence of
Table 6. p53 Signaling in SH-SY5Y (SY) Cells.
SY cells co-cultured with Bb SY cells co-cultured with microglia and Bb
Symbol Entrez Gene Name
Exp Val
Fold D Symbol Entrez Gene Name
Exp Val
Fold D
AKT1 v-akt murine thymoma viral oncogene homolog 1 q2.550 AKT1 v-akt murine thymoma viral oncogene homolog 1 q2.132
ATM ataxia telangiectasia mutated q0.908 AKT3 v-akt murine thymoma viral oncogene homolog 3 q0.868
BCL2 B-cell CLL/lymphoma 2 Q0.649 *BAX BCL2-associated X protein q0.826
BCL2L1 (Bcl-XL) BCL2-like 1 q0.703 *BCL2L1 (Bcl-XL) BCL2-like 1 Q1.267
CDKN2A (p16) cyclin-dependent kinase inhibitor 2A Q1.554 CDKN2A (p16) cyclin-dependent kinase inhibitor 2A Q2.397
DRAM damage-regulated autophagy modulator Q2.340 **CDK2 cyclin-dependent kinase 2 Q2.091
GADD45B growth arrest and DNA-damage-inducible, beta q1.089 **CDKN1A (p21) cyclin-dependent kinase inhibitor 1A q1.072
HIPK2 Homeodomain interacting protein kinase 2 Q0.707 FASN fatty acid synthase q1.189
MED1 mediator complex subunit 1 Q0.848 **GSK3B glycogen synthase kinase 3 beta q0.717
THBS1 thrombospondin 1 q0.624 MAPK14 mitogen activated protein kinase 14 Q0.788
*PMAIP1 (NOXA-1) phorbol-12-myristate-13-acetate-induced protein 1 q0.750
*PTEN phosphatase and tensin homolog q1.027
Changes in p53 Signaling gene expression indicate a microglial cell-induced shift in the state of SY cells co-cultured with B. burgdorferi (Bb) from one of cell survival and
proliferation, toward one of apoptosis and cell cycle arrest. Changes noted with a single asterisk represent a pro-apoptotic shift while those shown with a double
asterisk suggest preparation for cell cycle arrest at G1/S.
doi:10.1371/journal.ppat.1000659.t006
Table 7. Confirmation of SY array results using QRT-PCR.
Gene SY/Bb (fold change) P-value
ATM +2.02 0.001
DRAM 21.56 0.001
SY/mG/Bb (fold change)
PTEN +1.81 0.05
BAX +1.40 0.001
Bcl-XL 22.83 0.001
RT-PCR reactions were run in triplicate with GAPDH gene expression used as
the reference. PCR efficiencies, average fold change and statistics were
evaluated using REST software. SY: SHSY5Y ‘‘n’’ type neuroblastoma cells; Bb:
B. burgdorferi; mG: microglia.
doi:10.1371/journal.ppat.1000659.t007
Figure 5. Induction of neuronal apoptosis during co-culture
with B. burgdorferi and microglia may be influenced by or even
require cell-cell contact between neurons and microglia. The
TUNEL assay was used to evaluate apoptosis in SH-SY5Y (SY) neurons
and microglia (mG) co-cultured with B. burgdorferi (Bb) for 5 days. An
average 7.7 fold-increase in neuronal apoptosis was observed when SY
cells were co-cultured with primary microglia and B. burgdorferi as
compared to the SY cells cultured in medium alone. An increase in
neuronal cell apoptosis was also observed during the co-culture of SY
cells with primary microglia when B. burgdorferi was present. No
statistical changes in apoptosis were noted between the SY cells
cultured in medium alone and those co-cultured with either B.
burgdorferi alone, with microglia or co-cultured with microglia and B.
burgdorferi using 3.0-micrometer filter transwell inserts to physically
separate the cells (i). Values represent the mean (n=3) 6 S.D. P values
were obtained using One Way analysis of variance (ANOVA) followed by
Bonferroni, Tukey and Levine’s tests. Microglial cells in each experiment
were all obtained from the same animal, but different animals were
used as a source of cells for each of the three experiments.
doi:10.1371/journal.ppat.1000659.g005
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effects that activated microglia may have on neurons in their
surroundings.
Finally, although we have presented evidence of the ability of
microglia to harm SY cells through a bystander effect, our findings
indicate that microglia-SY cell proximity, while necessary, may not
be sufficient for end-stage SY cell damage/apoptosis to occur.
When transwell filter inserts were incorporated into our apoptosis
experiments, no significant increases in SY cell death were
observed regardless of whether microglia were included in the
co-cultures of SY cells with B. burgdorferi or not. This differed
significantly from a near 8-fold increase in SY cell apoptosis that
occurred when microglia (from the same animal) and SY cells were
in direct physical contact during their co-culture with B. burgdorferi,
indicating that neuronal-microglia contact was required for
apoptosis to occur. Several investigators have reported a similar
cell-cell contact requirement for apoptosis induced by activated
macrophages and other non-neuronal cells [62–64,90]. Whether
their contact with mediators secreted by B. burgdorferi-activated
microglia is itself enough to critically damage SY cells, or it simply
acts to prime the cells for eventual apoptosis, remains in question.
Due to viability constraints of the cell culture medium, we were
not able to extend our apoptosis assays beyond 5 days. We
therefore cannot exclude the possibility that longer exposure to
microglial mediators might have induced apoptosis in SY cells. If
this were the case, the cell-cell contact hypothesis would shift from
one of ‘‘requirement’’ to one of ‘‘influence’’. Further, even though
steps were taken to more normalize the SY cell-line phenotype,
these cells may respond differently than would non-transformed
neurons. While experiments with primary neurons would be
optimal, they are often not practical. Similar experiments with
other cell lines and even primary neurons may be critical to
understanding how B. burgdorferi affects neurons of the CNS during
neuroborreliosis.
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